Professor David Ridley will share insights from his new research that suggests that the way Medicare pays health care providers for drugs inadvertently encourages drug makers to charge higher prices.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Duke Fuqua Insights
Georgia Tech researchers received a grant from the Food and Drug Administration to develop a way to continuously manufacture common antibiotics like amoxicillin. This process could help reduce costs and avoid shortages.
What are these vouchers, why is the FDA issuing them and what benefit might they have for society?